IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • EMU Journal of Pharmaceutical Sciences
  • Volume:1 Issue:1
  • USE OF ANALGESICS AND REYE’S SYNDROME

USE OF ANALGESICS AND REYE’S SYNDROME

Authors : Keziban TİLKİ, Gönül ŞAHİN
Pages : 55-67
View : 18 | Download : 8
Publication Date : 2018-06-01
Article Type : Other Papers
Abstract :Non-steroidal inflammatory drug are commonly used as an analgesic, antipyretics and also antiinflammatory agents by many people at all ages in the world .Non-steroidal anti-inflammatory drugs are useful to relief for pain ,fever inflammation but they show only palliative therapy which also have common and /or rare adverse effects as well as therapeutic effects. Reye’s syndrome is rare, but very severe and serious side effect related to this group drugs. Therefore in the present study. Reye’s syndrome was examined in detail especially in children. Its prognosis, sign symptoms and reasons, treatment and relationship between use of the drugs and Reye’s Syndrome, were evaluated. According to evidences about this problem, it is clear that there is between some analgesic group relationship group drugs and RS. Additionally serious the role and duties of health personnel especially pharmacist to prevent or reduce the risk are emphasized in this study
Keywords : Reyes syndrome, Nonsteroidal anti inflammatory drugs

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025